Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12151998 | Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto | Stephen Warren Hunt, III, Martin Douglas Phillips, Robert Matunas, Herman Chen, Charles Uzarama +1 more | 2024-11-26 |
| 12029819 | Pharmaceutical compositions comprising lonafarnib and ritonavir | Patrick Gosselin | 2024-07-09 |
| 11890378 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Bruce Rehlaender, Roch Thibert | 2024-02-06 |
| 11590165 | Formulations of calcium and phosphate for oral inflammation | Bartholomew Weldon, Edward Kobus, Sandryne Dumoulin, Patrick Gosselin | 2023-02-28 |
| 11517532 | Methods of treating hepatitis delta virus infection | Patrick Gosselin | 2022-12-06 |
| 11471413 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Bruce Rehlaender, Roch Thibert | 2022-10-18 |
| 11452692 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Bruce Rehlaender, Roch Thibert | 2022-09-27 |
| 10933020 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Bruce Rehlaender, Roch Thibert | 2021-03-02 |
| 10925832 | Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activation | Bruce Rehlaender, Roch Thibert | 2021-02-23 |
| 10835496 | Pharmaceutical compositions comprising lonafarnib and ritonavir | Patrick Gosselin | 2020-11-17 |
| 10512619 | Solid oral formulation of fenretinide | Marc Lemieux, Roch Thibert | 2019-12-24 |
| 10406127 | Solid oral formulation of fenretinide | Marc Lemieux, Roch Thibert | 2019-09-10 |
| 10059660 | Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto | Stephen Warren Hunt, III, Martin Douglas Phillips, Robert Matunas, Herman Chen, Charles Uzarama +1 more | 2018-08-28 |
| 9546135 | Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto | Stephen Warren Hunt, III, Martin Douglas Phillips, Robert Matunas, Herman Chen, Charles Uzarama +1 more | 2017-01-17 |
| 8980918 | Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid | Marc Lemieux, Roch Thibert | 2015-03-17 |
| 8703956 | Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid | Marc Lemieux, Roch Thibert | 2014-04-22 |
| 8460640 | Narcotic drug formulations with decreased abuse potential | Robert Vinson, Patrick Gosselin | 2013-06-11 |